Dhawan, UdeshUdeshDhawanTseng, Ching LiChing LiTsengWu, Ping HsuanPing HsuanWuLiao, Mei YiMei YiLiaoWang, Huey YuanHuey YuanWangKEVIN CHIA-WEN WUChung, Ren JeiRen JeiChung2023-06-282023-06-282023-02-0115499634https://scholars.lib.ntu.edu.tw/handle/123456789/633232Metal-organic frameworks (MOFs) have emerged as attractive candidates in cancer theranostics due to their ability to envelop magnetic nanoparticles, resulting in reduced cytotoxicity and high porosity, enabling chemodrug encapsulation. Here, FeAu alloy nanoparticles (FeAu NPs) are synthesized and coated with MIL-100(Fe) MOFs to fabricate FeAu@MOF nanostructures. We encapsulated Doxorubicin within the nanostructures and evaluated the suitability of this platform for medical imaging and cancer theranostics. FeAu@MOF nanostructures (FeAu@MIL-100(Fe)) exhibited superparamagnetism, magnetic hyperthermia behavior and displayed DOX encapsulation and release efficiency of 69.95 % and 97.19 %, respectively, when stimulated with alternating magnetic field (AMF). In-vitro experiments showed that AMF-induced hyperthermia resulted in 90 % HSC-3 oral squamous carcinoma cell death, indicating application in cancer theranostics. Finally, in an in-vivo mouse model, FeAu@MOF nanostructures improved image contrast, reduced tumor volume by 30-fold and tumor weight by 10-fold, which translated to enhancement in cumulative survival, highlighting the prospect of this platform for oral cancer treatment.encancer theranostics | Hyperthermia | iron‑gold alloy nanoparticles | Metal-organic framework | Oral squamous carcinoma[SDGs]SDG3journal article10.1016/j.nano.2023.102652366237142-s2.0-85147090761https://api.elsevier.com/content/abstract/scopus_id/85147090761